NCT06123650 Post Stroke Dysphagia: Effect of Adding rTMS to Conventional Therapy on the Prevalence of Pneumonia.
| NCT ID | NCT06123650 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Cairo University |
| Condition | Stroke, Acute |
| Study Type | INTERVENTIONAL |
| Enrollment | 70 participants |
| Start Date | 2025-03-22 |
| Primary Completion | 2025-12-28 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 70 participants in total. It began in 2025-03-22 with a primary completion date of 2025-12-28.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
BACKGROUND: Dysphagia is one of the most life-threatening stroke complications. Dysphagic stroke patients are at increased risk of aspiration pneumonia. Pneumonia accounts for at least 10% of post stroke deaths within 30 days of hospitalization after stroke. rTMS is effective in improving post-stroke dysphagia and swallowing coordination after stimulation of the unaffected hemisphere, however it's efficacy on the prevalence of pneumonia has not yet been examined. Purpose of the study: To determine the effect of adding low frequency repetitive transcranial magnetic stimulation to conventional oropharyngeal physical therapy program on the prevalence of aspiration pneumonia in in patients with post stroke dysphagia.
Eligibility Criteria
Inclusion Criteria: 1. All the patients were diagnosed of stroke oropharyngeal dysphagia by a neurologist. Sever to moderate dysphagia (GUSS 0-14). 2. Severity of stroke ranged from mild to moderate according to NIHSS score (NIHSS less than or equal 16). 3. Patients' age ranged from 49 to 65 years old. 4. Patients had the ability to understand and follow instructions. 5. Patients were able to sit in upright position. Exclusion Criteria: 1. History of previous stroke. 2. History of any swallowing problem. 3. History of any head and neck surgery or tumor that causes swallowing dysfunction. 4. Any lung disease or pneumonia on admission. 5. Patients with cognitive deficits or disturbed conscious level. 6. Patients on mechanical ventilator. 7. Patients with sensory or global aphasia.
Contact & Investigator
Engy B. Moustafa, PhD
PRINCIPAL INVESTIGATOR
Faculty of Physical Therapy, Cairo University, Egypt
Frequently Asked Questions
Who can join the NCT06123650 clinical trial?
This trial is open to participants of all sexes, aged 49 Years or older, up to 65 Years, studying Stroke, Acute. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06123650 currently recruiting?
Yes, NCT06123650 is actively recruiting participants. Contact the research team at engybm.saleh@cu.edu.eg for enrollment information.
Where is the NCT06123650 trial being conducted?
This trial is being conducted at Giza, Egypt.
Who is sponsoring the NCT06123650 clinical trial?
NCT06123650 is sponsored by Cairo University. The principal investigator is Engy B. Moustafa, PhD at Faculty of Physical Therapy, Cairo University, Egypt. The trial plans to enroll 70 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.